How diabetes drug metformin inhibits progression of pancreatic cancer

Status
Not open for further replies.

Northerner

Admin (Retired)
Relationship to Diabetes
Type 1
Massachusetts General Hospital (MGH) investigators may have uncovered a novel mechanism behind the ability of the diabetes drug metformin to inhibit the progression of pancreatic cancer. In their report that has been published in the open access journal PLOS One, the research team describes finding that metformin decreases the inflammation and fibrosis characteristic of the most common form of pancreatic cancer. Their findings in cellular and animal models and in patient tumor samples also indicate that this beneficial effect may be most prevalent in overweight and obese patients.

http://www.sciencedaily.com/releases/2016/01/160114121730.htm

Yes, it's that drug again! 🙂
 
If its such a wonder drug then why isn't every 50 year old put on it??? :D
 
Global warming and greenhouse gases? 😱 😉

thumbup.gif
 
Status
Not open for further replies.
Back
Top